• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Logo of plosonePLoS OneView this ArticleSubmit to PLoSGet E-mail AlertsContact UsPublic Library of Science (PLoS)
PLoS One. 2011; 6(12): e28176.
Published online Dec 9, 2011. doi:  10.1371/journal.pone.0028176
PMCID: PMC3235109

Quantitative and Qualitative Analyses of the Cell Death Process in Candida albicans Treated by Antifungal Agents

Andre Van Wijnen, Editor

Abstract

The death process of Candida albicans was investigated after treatment with the antifungal agents flucytosine and amphotericin B by assessing morphological and biophysical properties associated with cell death. C. albicans was treated varying time periods (from 6 to 48 hours) and examined by scanning electron microscopy (SEM) and atomic force microscopy (AFM). SEM and AFM images clearly showed changes in morphology and biophysical properties. After drug treatment, the membrane of C. albicans was perforated, deformed, and shrunken. Compared to the control, C. albicans treated with flucytosine was softer and initially showed a greater adhesive force. Conversely, C. albicans treated with amphotericin B was harder and had a lower adhesive force. In both cases, the surface roughness increased as the treatment time increased. The relationships between morphological changes and the drugs were observed by AFM clearly; the surface of C. albicans treated with flucytosine underwent membrane collapse, expansion of holes, and shrinkage, while the membranes of cells treated with amphotericin B peeled off. According to these observations, the death process of C. albicans was divided into 4 phases, CDP0, CDP1, CDP2, and CDP4, which were determined based on morphological changes. Our results could be employed to further investigate the antifungal activity of compounds derived from natural sources.

Introduction

Candida albicans (C. albicans) is a dimorphic organism that forms either a yeast or a mycelium depending on the growth environment. C. albicans is normally present on the skin and in mucous membranes such as the vagina, mouth, and rectum in 80% of the human population with no harmful effects; overgrowth results in candidiasis, which is generally easily cured [1][5]. However, candidiasis can sometimes result in serious opportunistic infections when the immune system is compromised, and is an important cause of morbidity and mortality in immunocompromised patients with diseases such the human immunodeficiency virus (HIV), or undergoing chemotherapy, organ or bone marrow transplantation. Mortality associated with candidiasis can be as high as 30–50% in patients undergoing transplantation and 40% of those with HIV [5].

The current antifungal agents available to treat candidiasis can be divided into two groups depending on mechanism of action [6]. One group acts mainly on cell walls or membranes, while the other attacks intracellular pathways. The antifungal agents of the former group are typically azole-type drugs, which are ergosterol inhibitors or b-glucagon synthase inhibitors [6]. Those in the latter group include pyrimidine analogues, thymidylate synthase inhibitors, and mitotic inhibitors [6]. However, treatment of C. albicans infections with these drugs may lead to side effects such as hepatotoxicity and nephrotoxicity [7], resistance, and frequent recurrence. For these reasons, treatment using home remedies has been widely introduced worldwide, and new antifungal agents from natural resources are being studied intensively. Several natural compounds show antifungal activity, including Euphorbia hirta L [3], Eqoul, which is found in soybean [4], Tribulus terrestris L [8], and Allicin, which is found in garlic [7]. Despite several reports describing drugs extracted from natural resources, thus far, very little is known about their antifungal activities.

In this work, we demonstrate the death process of C. albicans after the use of two commonly used antifungal agents, flucytosine and amphotericin B. Both have been used in the treatment of candidiasis, and their mechanisms of actions are well known. We investigated changes in morphology and biophysical properties of C. albicans treated with flucytosine and amphotericin B using scanning electron microscopy (SEM) and atomic force microscopy (AFM). The findings of this work may be used in future studies to investigate the antifungal activities of natural drugs.

Results

The antifungal activities of flucytosine and amphotericin B were estimated using a cell viability assay. The rates of C. albicans viability as a function of drug treatment time from 0 (control) to 48 hours are shown in Figure 1. The inset shows results for treatment times from h = 6 to h = 48. When C. albicans was exposed to either antifungal drugs for h = 6, the viability decreased by 90%. When the cells were exposed for longer periods (h>12), the viability increased according to treatment time. This result was not unexpected, as it represented not a waning of the effects of the antifungal drugs but the budding of new cells that were unaffected by the drug. The increase in viability was greater in flucytosine treated cells than in amphotericin B treated cells, indicating that C. albicans is more sensitive to amphotericin B.

Figure 1
Cell viability of C. albicans as a function of antifungal drug treatment time.

SEM images of C. albicans cells untreated (A), treated with flucytosine (B) or treated with amphotericin B (C) revealed ultrastructural changes in the C. albicans due to the antifungal drugs (Fig. 2). Untreated cells had well defined, intact shapes with smooth surfaces. Cells treated with drugs showed considerable morphological alterations including deformation and shrinkage. In both cases, the cells were significantly destroyed when treated more than 12 hours.

Figure 2
SEM images of C. albicans cells.

Representative AFM images of the C. albicans treated with flucytosine (A) and amphotericin B (B) are shown in Figure 3. The AFM images clearly show nanoscale morphological changes induced by the antifungal drugs. The most dramatic changes in the membrane of C. albicans after treatment with antifungal drugs were observed when the cells were exposed to the drugs for 6 hours. Cells treated with flucytosine were just starting to show collapse of the outer membrane and their shape was becoming irregular compared to the untreated cells (Fig. 3A). In the case of cells treated with amphotericin B (Fig. 3B), the outer membranes were peeling off instead of collapsing. For treatments longer than 12 hours, both cell treatments showed similar changes in the shape and morphology including deformation and shrinkage. These changes are similar to the results observed with SEM.

Figure 3
AFM images of C. albicans cells.

AFM provides a three-dimensional image of the cell surface on a nanometer scale. In the treated cells, the three dimensional structures of C. albicans differed in Z axis values according to the drug treatment time. In cells treated with flucytosine, the Z axis values were 240 nm/div, 150 nm/div and 80 nm/div at h = 6, 12, and 18, respectively (Fig. 4B). In cells treated with amphotericin B, the values were 300 nm/div, 200 nm/div, and 100 nm/div at h = 6, 12, and 18, respectively (Fig. 4B).

Figure 4
Three-dimensional AFM images.

According to SEM and AFM images, the cell death phase (CDP) of C. albicans can be divided into four steps (Fig. 5). The first step is CDP0, in which the cells are not visibly affected by the drug and show very clear, intact, and defined shapes. The second step is CDP1, in which the cell shape is partially deformed, collapsed or peeled off depending on the type of antifungal drug used. The third step is CDP2, in which the cells lose their original shapes and porosity is expanded. The width and depth of the hole is about 50–70% of the cell diameter. The final step is CDP3, in which the cells are shrunken and completely destroyed.

Figure 5
Cell death phase (CDP) of C. albicans induced by flucytosine and amphotericin B.

The effects of antifungal drugs on the biophysical properties of C. albicans were also investigated using AFM measurements. Obvious changes in stiffness, adhesive force, and roughness were observed in both groups of treated cells (Fig. 6), but the changes seen were dependent on the type of antifungal drug used. Compared to untreated cells, the cells treated with flucytosine were softer, while the cells treated with amphotericin B were harder (Fig. 6a). The stiffness did not change with the use of CDP in either case. The adhesive force of cells treated with flucytosine was lower than that of untreated cells (Fig. 6b). The adhesive force of cells treated with amphotericin B was greater than that of the untreated cell at CDP1, but decreased to a similar or lower value than CDP0 at CDP2 and CDP3. Since the membrane shrinks as the cell is destroyed, the roughness of the cell surface was increased in both groups of treated cells (Fig. 6c).

Figure 6
Changes in biophysical properties of C. albicans according to CDP.

Discussion

Although C. albicans is most often associated with candidiasis, the development of a universal therapeutic approach to C. albicans infection is still a great challenge because of the vast problems faced with conventional treatments such as toxicity, side effects, resistance, and relapse [3]. The use of natural products and home remedies for the treatment of candidiasis has been gaining popularity both in practical use and in research. Studies of natural drugs showing in vitro antifungal activities were first performed by Maruzzella and others in 1958 [9]. Since then, a variety of natural antifungal compounds have been discovered [3], [4], [7], [8], but the mechanisms of action of these natural compounds are not yet fully understood. To understand the antifungal activity of drugs from natural sources, it is necessary to clearly show the death process of C. albicans in both quantitative and qualitative terms. Thus, in this work, the CDP of C. albicans induced by two commonly used antifungal drugs of flucytosine and amphotericin B was investigated using SEM and AFM by measuring cell viability, and morphological and biophysical properties.

Antifungal agents affect the morphology and physical properties of cells, such as shape, size, height, roughness and stiffness [10][13]. Adherence of cells is also affected by antifungal agents. Several works suggested that the activity of antifungal agents can be evaluated by changes in morphology and physical properties of the fungal cells. Using transmission electron microscopy (TEM), SEM, and AFM, morphological changes in C. albicans have been investigated qualitatively. TEM is a microscopy technique to use a beam of electrons, which is transmitted through a thin sample and interacted with the sample as it passes through. Therefore, it is usually employed to see inner part of the sample. The SEM images a sample by scanning it with a high-energy beam of electrons, and it is capable of imaging at a significantly higher resolution than light microscopes. However, for SEM imaging, a biological sample should be completely dry, because the sample chamber is at high vacuum. Tyagi et al. investigated the antimicrobial activity of lemon grass oil against C. albicans observed by in situ TEM, SEM, and AFM [10] and determined that C. albicans treated with LGO vapor ruptured completely, cells treated with LGO in broth shrank and that the surface roughness of cells treated with LGO was significantly higher in control C. albicans than in treated cells. In recent years, it has been increased the preference of AFM in biomaterial imaging since its several advantages over the other spectroscopy. AFM provides not only a two-dimensional image of a sample but also a three-dimensional surface profile. For AFM imaging, the samples do not require any special treatments such as coatings with metal or carbon, and dry. Additionally, the images can be obtained in ambient air or even a liquid environment. Adya et al. investigated the toxic effects of ethanol on yeast cell surface morphology using AFM [11]. The cell surface morphological changes were correlated with cellular stress physiology. By exposing yeast to increasingly stressful concentrations of ethanol, cell viabilities and mean cell volumes were decreased.

In this work, the morphological changes of C. albicans induced by antifungal drugs were clearly revealed by SEM and AFM. Especially, the dependence of morphological changes on the mechanism of action of antifungal agents was clearly distinguished in the AFM images. As shown in Fig. 3(A), the death process of C. albicans treated by flucytosine was accompanied by membrane collapse, expansion of the hole, and shrinkage. These changes can be understood by the mechanism of action of the flucytosine. The flucytosine is a fluorinated pyrimidine analog which mainly acts on RNA and DNA. It shows antifungal activity by inhibiting RNA and fungal replication by DNA synthesis inhibition [14] and is metabolized into 5-fluorouracil. The damaged RNA and DNA prevent a normal metabolism, a protein synthesis, and are accompanied by the destruction of microtubule. According to this mechanism, it thought to be that the interior of the cell is firstly destroyed by the flucytosine and it eventually results the collapses the outer membrane. While the C. albicans treated with amphotericin B shows a quite different cell death process as shown in Fig. 3(B). The membranes of cells treated with amphotericin B were firstly peeled off, this exfoliation was observed mainly after 6 hours treatment. By the further treatment, the membrane was holed and shrunk as like the cell treated by flucytosine. These morphological changes also show a good agreement with the mechanism of action of amphotericin B. The Amphotericin B which is antifungal polyene is known to acts on cell walls and membranes even though the precise mechanism still remains unclear [15]. This drug binds to ergosterol, which is the principal sterol in membrane of fungal cell, and then destroys the integrity of the fungal membrane. Fortunately, the very subtle changes in the membrane were detected by AFM.

Physical properties of the cells, such as roughness, stiffness, and adhesive force, were also obtained by using AFM, and the changes induced by antifungal drugs were determined quantitatively. Cells treated with flucytosine were softer than untreated cells, while cells treated with amphotericin B were harder than untreated cells. Although it is not yet fully understood how cell stiffness is regulated, it is known that the stiffness of cell is largely determined by physical property of membrane, cytoskeletal architecture, and the network of intermediate filaments. Because of this fact, the cell stiffness can provide insight into the status and function of the cells. Several studies reported that the cell stiffness changed with the progression of diseases [16], [17]. The change in the cell stiffness observed in this work is related to the cell death caused by antifungal agent. The lowered stiffness in the cell treated with flucytosine can be understood by the mechanism of action of flucytosine. As mentioned before, the flucytosine mainly acts on RNA and DNA synthesis and results in the metabolic disorder. Therefore, the destroyed cytoskeletal architecture or microtubule is responsible for the softness of the membrane. The change in the stiffness was not significantly dependent on the progression of cell death. The larger stiffness in cells treated with amphotericin B is not well understood, however, it clearly shows that the changes in physical property of the cell depend on variety of antifungal agents.

In both cells, it was not observed a significant change in the adhesive force except the cell treated with amphotericin B at CDP1. The adhesive force is the strength of the interaction between the cell membrane and AFM tip. The force depends on the sample conditions and dimensions of the tip, which changes with humidity, temperature, and tip diameter [18]. To minimize these problems in this work, all images were measured with the tip manufactured in the same process and the similar environmental conditions. The adhesive force is also very sensitivity to the properties of the sample, such as hydrophobic or hydrophilic because of the AFM tip property. The tip used in this work is made by silicon which is hydrophobic naturally, but the silicon is easily oxidized in air and turns to hydrophilic [19]. The membrane is hydrophobic naturally, and its property does not changed during the cell death process. Therefore, the larger adhesive force at CDP1 in the cell treated with amphotericin B may be due to internal secretion occurring after destruction of the cell membrane. Strictly speaking, it is not an adhesive force of the cell, but a force caused by certain sticky substance secreted in the cell.

In conclusion, the effects of two antifungal drugs on C. albicans were investigated by SEM and AFM. It was observed the morphological changes according to the treatment conditions, and the changes in the biophysical properties were determined quantitatively. The cell death process was defined based on the changes of morphology and biophysical properties. These findings will be applied to further analysis of antifungal activity of compounds derived from natural sources.

Materials and Methods

Culture and preparation of C. albicans

C. albicans was purchased from the American Type Culture Collection (ATCC, Rockville, MD, USA), maintained in Sabouraud broth, and incubated at 37°C for 24 hours in a shaking incubator at 180 rpm. The samples were centrifuged at 2500 rpm for 15 minutes and washed in calcium-, magnesium-free phosphate-buffered saline (DPBS), and cells were used immediately.

Viability of C. albicans after antifungal treatment

For measurements of antifungal cytotoxicity, C. albicans was inoculated at 1×106 cells/ml in Sabouraud broth. C. albicans in cell suspension were treated with the minimum inhibitory concentrations (MIC)90 of antifungal agents, 1 µg/ml amphotericin B and 1 µg/ml flucytosine. After variable incubation times in a shaking incubator at 180 rpm, C. albicans cells were centrifuged at 2500 rpm for 15 minutes and then washed with 0.1 M PBS. For the assessment of cell cytotoxicity, cells were counted using a hemocytometer after stained with trypan blue dye (1[ratio]1) to exclude non-viable cells. The MIC90 of each drug was determined according to Graziella et al. [20].

Scanning electron microscopy (SEM)

For SEM measurements, Candida cells were smeared on a conducting layer as a thin film, and the samples were platinum-coated by sputtering. SEM observations were made using a FEI Company W-filament SEM embedded in a Focus Ion Beam. All observations were conducted under the conditions of EHT = 10.00 kV, Current = 0.12 nA, WD = 15 mm.

Atomic force microscopy (AFM)

The AFM system used in this study was the NANOStation II (Surface Imaging Systems, Herzogenrath, Germany), which consists of an AFM scanner and Zeiss optical microscope (Epiplan 500×). The images of C. albicans were measured in contact mode (Budget Sensor, Bulgaria) with a reflex-coated silicon cantilever. The properties of the probe used in imaging were: resonance frequency of 190 kHz (±14 kHz) and force constant of 48 N/m (±1.4 N/m). The images were taken with a resolution of 256×256 pixels and a scan speed of 0.2 line/s.

To perform force-distance (FD) curve measurements, the sample surface was first scanned to determine an appropriate site for the force curve without defects or impurities. Cell elasticity was quantified by the following equations: 1/kcell = 1/keffective−1/kcantilever, where keffective and kcantilever was determined from the slope of the linear region of the FD curve for a cell and a clean slide glass, respectively [21].

Footnotes

Competing Interests: The authors have declared that no competing interests exist.

Funding: This study was supported by a grant from Kyung Hee University in 2011 (KHU-20110093) and the Seoul Research and Business Development program (Grant No. CR070054). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

1. Michael JK, Paul AV. Ecology of candida albicans gut colonization: Inhibition of candida adhesion, colonization, and dissemination from the gastrointestinal tract by bacterial antagonism. Infection and Immunity. 1985;49:654–663. [PMC free article] [PubMed]
2. Amit KT, Anushree M. Liquid and vapour-phase antifungal activities of selected essential oils against candida albicans: microscopic observations and chemical characterization of cymbopogon citrates. Tyagi and Malik BMC Complementary and Alternative Medicine. 2010;10:1–11. [PMC free article] [PubMed]
3. Abu AB, Zakaria Z, Sreenivasan S. A transmission lectron microscopy study of the diversity of candida albicans cells induced by euphorbia hirta L. leaf extract in vitro. Asian Pacific Journal of Tropical Biomedicine. 2011;1:20–22. [PMC free article] [PubMed]
4. Lee JA, Chee HY. In vitro antifungal activity of equol against candida albicans. Microbiology. 2010;38:328–330. [PMC free article] [PubMed]
5. Mihai GN, Neil AR, Carol AM, Steven B, Claire C, et al. Immune sensing of Candida albicans requires cooperative recognition of mannans and glucans by lectin and Toll-like receptors. The Journal of Clinical Investigation. 2006;116:1642–1650. [PMC free article] [PubMed]
6. Laing R, Waning B, Gray A, Ford N, Nathan F, et al. 25 years of the WHO essential medicines lists: progress and challenges. Lancet. 2003;361:1723–1729. [PubMed]
7. Alireza K, Fahimeh A, Farzad A, Zamberi S, Pei PC. In vitro investigation of antifungal activity of allicin alone and in combination with azoles against candida species. Mycopathologia. 2009;169:287–295. [PubMed]
8. Zhang J-D, Xu Z, Cao Y-B, Chen H-S, Yan L, et al. Antifungal activities and action mechanisms of compounds from Tribulus terrestris L. Journal of Ethnopharmacology. 2006;103:76–84. [PubMed]
9. Maruzzella JC, Liguori L. The in vitro antifungal activity of essential oils. J Am Pharm Assoc Am Pharm Assoc (Baltim) 1958;47:250–254. [PubMed]
10. Amit KT, Anushree M. In situ SEM, TEM and AFM studies of the antimicrobial activity of lemon grass oil in liquid and vapour phase against Candida albicans. Micron. 2010;41:797–805. [PubMed]
11. Elisabetta C, Ashok KA, Graeme MW. Atomic forcemicroscopic studyof the e¡ectsof ethanol on yeast cell surfacemorphology. FEMS Microbiol Lett. 2006;255:308–315. [PubMed]
12. Antonio MV, Amparo MG, Ciro PGo, María LG, María JN. Surface morphological characterization of yeast cells by scanning force microscopy. Surf Interface Anal. 2001;31:1027–1030.
13. Boonaert CJP, Rouxhet PG, Dufrene YF. Surface properties of microbial cells probed at the nanometer scale with atomic force microscopy. Surf Interface Anal. 2000;30:32–35.
14. Vermes A, Guchelaar HJ, Dankert J. Flucytosine: a review of its pharmacology, clinical indications, pharmacokinetics, toxicity and drug interactions. J Antimicrob Chemother. 2000;46:171–179. [PubMed]
15. Baginski M, Czub J. Amphotericin B and its new derivatives-mode of action. Curr Drug Metab. 2009;10:459–469. [PubMed]
16. Jochen G, Stefan S, Bryan L, Falk W, Susanne E, et al. Optical Deformability as an Inherent Cell Marker for Testing Malignant Transformation and Metastatic Competence. Biophysical Journal. 2005;88:3689–3698. [PMC free article] [PubMed]
17. Wilbur AL, Michael JR, Daniel AF. Chemotherapy exposure increases leukemia cell stiffness. Blood. 2007;109:3505–3508. [PMC free article] [PubMed]
18. Bhushan B, Dandavate C. Thin film friction and adhesion studies using atomic force microscopy. J of Appl Phys. 2000;87:1201–1210.
19. Grundner M, Jacob H. Investigations on hydrophilic and hydrophobic silicon (100) wafer surfaces by X-ray photoelectron and high-resolution electron energy loss-spectroscopy. Applied Physics A. 1986;39:73–82.
20. Brito GN, Inocêncio AC, Querido SM, Jorge AO, Koga-Ito CY. In vitro antifungal susceptibility of Candida spp. oral isolates from HIV-positive patients and control individuals, Braz. Oral Res. 2010;25:28–33. [PubMed]
21. Volle CB, Ferguson MA, Aidala KE, Spain EM, Núñez ME. Quantitative changes in the elasticity and adhesive properties of Escherichia coil ZK1056 prey cells during predation by bdellovibrio bacteriovorus 109J. Langmuir. 2008;24:8102–8110. [PubMed]

Articles from PLoS ONE are provided here courtesy of Public Library of Science
PubReader format: click here to try

Formats:

Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...

Links

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...